Nakai, Yuta
NOF Corporation (Japan)
4 papers on CoChatORCID 0000-0003-2695-6097
Most cited papers
- Verified
Self-degradable lipid-like materials based on “hydrolysis accelerated by the intra-particle enrichment of reactant (HyPER)” for messenger RNA delivery
Tanaka, H., Takahashi, T., Konishi, M., Takata, N., Gomi, M., Shirane, D., Miyama, R., Hagiwara, S., Yamasaki, Y., Sakurai, Y., et al. (2020) · Advanced Functional Materials
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 126
- Verified
In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration
Tanaka, H., Nakatani, T., Furihata, T., Tange, K., Nakai, Y., Yoshioka, H., Harashima, H., & Akita, H. (2018) · Molecular Pharmaceutics
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 82
- Verified
Effects of corticostatin-I on rat adrenal cells in vitro
Tominaga, T., Fukata, J., Naito, Y., Nakai, Y., Funakoshi, S., Fujii, N., & Imura, H. (1990) · Journal of Endocrinology
Adrenal Hormones and DisordersHormonal Regulation and Hypertension
Cited by 58
- Verified
Development of an alcohol dilution-lyophilization method for preparing lipid nanoparticles containing encapsulated siRNA
Shirane, D., Tanaka, H., Nakai, Y., Yoshioka, H., & Akita, H. (2018) · Biological and Pharmaceutical Bulletin
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free